Journal of International Oncology››2012,Vol. 39››Issue (3): 234-236.
Previous ArticlesNext Articles
HAN Xue-Chuan, FAN Yang
Online:2012-03-08Published:2012-02-24Contact:FAN Yang, E-mail: yangf0803@126.com E-mail:yangf0803@126.com| [1] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
| [2] | Yue Hongyun, Zhang Baihong.Differentiation therapies in human cancers[J]. Journal of International Oncology, 2024, 51(2): 109-113. |
| [3] | Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104. |
| [4] | Li Chenxi, Zhao Hongwei.Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery[J]. Journal of International Oncology, 2023, 50(6): 342-347. |
| [5] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
| [6] | Chen Yi, Han Liang, Cai Li.Multivariate analysis of chemotherapy induced oral mucositis in patients with head and neck tumors[J]. Journal of International Oncology, 2022, 49(9): 521-525. |
| [7] | Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie.Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer： a study based on real-world data[J]. Journal of International Oncology, 2022, 49(7): 408-415. |
| [8] | Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali.Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer[J]. Journal of International Oncology, 2022, 49(5): 276-281. |
| [9] | Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(3): 140-145. |
| [10] | Lao Zheng, Tu Wenyong, Xu Xuanli, Zhang Lin, Shao Ziyang, Shi Huifeng.Nimotuzumab combined with definitive radiotherapy for inoperable locally advanced oral and maxillofacial squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(11): 665-670. |
| [11] | Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50. |
| [12] | Long Xin, Wu Han, Peng Jin, Zhou Fuxiang.Systemic therapy of advanced biliary tract cancer[J]. Journal of International Oncology, 2021, 48(5): 302-307. |
| [13] | Song Yang, Wang Bin, Xiao He, Chen Chuan, Wang Ge, Geng Mingying.Predictive value of tumor regression rate after induction chemotherapy for survival of patients with locally advanced nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(3): 156-163. |
| [14] | Chi Xiuying, Wang Hongbiao, Li Zhifeng, Lin Yingcheng.Progression in the therapies of relapse or metastatic esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2021, 48(12): 755-759. |
| [15] | Wang Xuan, Cui Lichun, Dang Shengqiang.Effects of apatinib combined with chemoradiotherapy on the efficacy and tumor markers of advanced gastric cancer[J]. Journal of International Oncology, 2021, 48(10): 602-607. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
